Fernand Labrie

Publications

Page 4 of 4, showing 41 records out of 191 total, starting on record 151, ending on 191

Publication Category Year
546. Kelly, P.A., Asselin, J., Caron, M.G., Raynaud, J.P., Labrie, F. (1977) High inhibitory activity of a new antiestrogen RU16117 (11?-methoxy-ethinyl estradiol) on the development of dimethylbenz(?)anthracene-induced mammary tumors. Cancer Res., 37: 76-81. Breast Cancer 1977
539. Kelly, P.A., Asselin, J., Labrie, F. (1979) Endocrine regulation of growth and hormone receptor levels in DMBA-induced mammary tumors, in: Thompson, E.B. et Lippman, M.E., eds: Steroids Receptors and the Management of Cancer, Boca Raton, Florida, CRC Press Inc., pp 3-29. Breast Cancer 1979
547. Kelly, P.A., Asselin, J., Labrie, F., Raynaud, J.P. (1977) Regulation of hormone receptor levels and growth of DMBA-induced mammary tumors by RU16117 and other steroids in the rat, in: McGuire, W.L., Baulieu, E.E. et Raynaud, J.P., eds: Progesterone Receptors in Normal and Neoplastic Tissues, New-York, Raven Press, pp 85-101. Breast Cancer 1977
540. Kelly, P.A., Asselin, J., Turcot-Lemay, L., Labrie, F., Raynaud, J.P. (1979) Effects of progesterone and R2323 on the development of dimethylbenz(??anthracene-induced mammary tumors. Eur. J. Cancer, 15: 1243-1251. Breast Cancer 1979
321. Labrie, F. (1981) Changing the message from the brain. People, 8: 16-17. Breast Cancer 1981
340. Labrie, F., Auclair, C., Cusan, L., Lemay, A., Pelletier, G., Kelly, P.A., Bélanger, A., Séguin, C., Raynaud, J.P. (1979) Antifertility effects of LHRH and its agonists in male and female rats: possible luteolytic effects of LHRH in women, in: Talwar, G.P., ed. Recent Advances in Reproduction and Regulation of Fertility, Elsevier-North Holland, Biomedical Press, pp 57-71. Breast Cancer 1979
77. Labrie, F., Bélanger, A., Luu-The, V., Labrie, C., Simard, J., Cusan, L., Gomez, J.L., Candas, B. (1998) DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids, 63: 322-328. Breast Cancer 1998
323. Labrie, F., Bélanger, A., Séguin, C., Cusan, L., Pelletier, G., Lefebvre, F.A., Kelly, P.A., Ferland, L., Reeves, J.J., Lemay, A., Raynaud, J.P. (1981) Inhibition of testicular and ovarian functions by LHRH agonists, in: Jagiello, G. et Vogel, H.J., eds: Bioregulators of Reproduction, New York, NY, USA, Academic Press, pp 305-341. Breast Cancer 1981
324. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Kelly, P.A., Lefebvre, F.A., Massicotte, J., Borgus, J.P., Lemay, A., van der Ohe, M. (1981) Antifertility effects of LHRH agonists, in: Semm, K. et Mettler, L., eds: Proc. III World Congress on Human Reproduction, Excerta Medica, ICS 551, pp 116-125. Breast Cancer 1981
325. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Massicotte, J., Kelly, P.A., Borgus, J.P. (1981) LHRH and sexual functions: inhibition at the pituitary and gonadal levels, in: Bizollon, C.A., ed. Physiological peptides and new trends in radioimmunology, Elsevier-North Holland, Biomedical Press, pp 57-70. Breast Cancer 1981
551. Labrie, F., Kelly, J., Asselin, J., Raynaud, J.P. (1976) Potent inhibitory activity of a new antiestrogen, RU 16117, on the development and growth of DMBA-induced rat mammary adenocarcinoma, in: St. Arneault, G., Band, P. et Israel, L., eds: Recent results in Cancer Research, Breast Cancer, a multidisciplinary approach, Springer-Verlag, pp 109-120. Breast Cancer 1976
352. Labrie, F., Savary, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Endocrinology, 98: 289-94. Breast Cancer 1976
262. Labrie, F., Veilleux, R. (1986) A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate, 8: 293-300. Breast Cancer 1986
514. Labrie, F., Veilleux, R., Fournier, A. (1988) Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in culture. Mol. Cell. Endocrinol., 58: 207-211. Breast Cancer 1988
214. Labrie, F., Veilleux, R., Fournier, A. (1988) Low androgen levels induce the development of androgen hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 1138-1147. Breast Cancer 1988
215. Labrie, F., Veilleux, R., Fournier, A. (1988) Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 966-970. Breast Cancer 1988
218. Luthy, I., Bégin, D., Labrie, F. (1988) Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17?-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture. Endocrinology, 123: 1418-1424. Breast Cancer 1988
524. Luthy, I., Caron, S., Bélanger, A., Labrie, F. (1987) Effect of flutamide, a pure antiandrogen, on the pituitary-ovarian axis in the adult female rat. Gynecol. Endocrinol., 1: 151-168. Breast Cancer 1987
219. Luthy, I.A., Bégin, D.J., Labrie, F. (1988) Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J. Steroid Biochem., 31: 845-852. Breast Cancer 1988
505. Marchetti, B., Spinola, P., Plante, M., Poyet, P., Folléa, N., Pelletier, G., Labrie, F. (1989) ?-adrenergic receptors in dimethylbenz(?)anthracene(DMBA)-induced rat mammary tumors: Correlation with progesterone receptor levels and tumor growth. Breast Cancer Res. Treat., 13: 251-263. Breast Cancer 1989
4726. Pelletier, G., Luu-The, V., Tetu, B., Labrie, F. (1999) Immunocytochemical localization of type 5 17beta-hydroxysteroid dehydrogenase in human reproductive tissues. J. Histochem Cytochem., 47: 731-738. Breast Cancer 1999
224. Plante, M., Lapointe, S., Labrie, F. (1988) Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. J. Steroid Biochem., 31: 61-64. Breast Cancer 1988
520. Poirier, D., Poulin, R., Labrie, F. (1988) Screening of lipoidal steroid formation in the ZR-75-1 human breast cancer cell line, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Progress in Cancer Research and Therapy. Hormones and Cancer, New York, Raven Press, pp 384-387. Breast Cancer 1988
521. Poulin, R., Baker, D., Labrie, F. (1988) Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213-225. Breast Cancer 1988
506. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1989) Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 13: 161-172. Breast Cancer 1989
507. Poulin, R., Dufour, J.-M., Labrie, F. (1989) Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Breast Cancer Res. Treat., 13: 265-276. Breast Cancer 1989
528. Poulin, R., Labrie, F. (1986) Stimulation of cell proliferation and estrogenic response by adrenal C19-?5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res., 46: 4933-4937. Breast Cancer 1986
525. Poulin, R., Labrie, F. (1987) Estrogenic effect of adrenal steroids in the human mammary carcinoma cell line ZR-75-1, in: Genazzani, A.R., Volpé, A. et Facchinetti, F., eds: Proceedings of the First International Congress on Gynecological Endocrinology, London, Parthenon Publishig Group, pp 561-568. Breast Cancer 1987
522. Poulin, R., Mérand, Y., Labrie, F. (1988) Antiestrogenic properties of a 7?-alkylated derivative of 17?-estradiol in ZR-75-1 human breast cancer, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent Research in Gynecological Endocrinology, Parthenon Publishing Group, pp 631-634. Breast Cancer 1988
508. Poulin, R., Mérand, Y., Poirier, D., Lévesque, C., Dufour, J.M., Labrie, F. (1989) Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI 164384, a new steroidal derivative, in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 14: 65-76. Breast Cancer 1989
509. Poulin, R., Poirier, D., Mérand, Y., Thériault, C., Bélanger, A., Labrie, F. (1989) Extensive esterification of adrenal C19-?5 sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. J. Biol. Chem., 264: 9335-9343. Breast Cancer 1989
510. Poulin, R., Simard, J., Labrie, C., Petitclerc, L., Dumont, M., Lagacé, L., Labrie, F. (1989) Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line. Endocrinology, 125: 392-399. Breast Cancer 1989
472. Simard, J., Feunteun, J., Lenoir, G., Tonin, P., Normand, T., Luu-The, V., Vivier, A., Lasko, D., Morgan, K., Rouleau, G.A., Lynch, H., Labrie, F., Narod, S.A. (1993) Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21: exclusion of candidate genes EDH17B2 and RARA. Hum. Mol. Genet., 2: 1193-1199. Breast Cancer 1993
511. Simard, J., Hatton, A.-C., Labrie, C., Dauvois, S., Zhao, H., Haagensen, D.E., Labrie, F. (1989) Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Mol. Endocrinol., 3: 694-702. Breast Cancer 1989
526. Simard, J., Labrie, F. (1987) Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs. J. Steroid Biochem., 26: 539-546. Breast Cancer 1987
529. Simard, J., Labrie, F., Gossard, F. (1986) Regulation of growth hormone mRNA and pro-opiomelanocortin mRNA levels by cyclic AMP in rat anterior pituitary cells in culture. DNA, 5: 263-270. Breast Cancer 1986
467. Simard, J., Tonin, P., Durocher, F., Morgan, K., Rommens, J., Gingras, S., Samson, C., Leblanc, J.F., Bélanger, C., Dion, F., Skolnick, M., Liu, Q., Shattuck-Eidens, D., Goldgar, D., Labrie, F., Narod, S.A. (1994) Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nat. Genet., 8: 392-398. Breast Cancer 1994
530. Spinola, P.G., Marchetti, B., Labrie, F. (1986) Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res. Treat., 8: 241-248. Breast Cancer 1986
523. Spinola, P.G., Marchetti, B., Mérand, Y., Labrie, F. (1988) Effects of the aromatase inhibitor 4-hydroxyandrostenedione and antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res. Treat., 12: 287-296. Breast Cancer 1988
536. Turcot-Lemay, L., Cusan, L., Séguin, C., Kelly, P.A., Labrie, F. (1981) Effect of an LHRH analog on growth and hormone receptor levels in dimethylbenz(?)anthracene-induced mammary tumors in the rat. J. Receptor Res., 2: 135-151. Breast Cancer 1981
436. Turgeon, C., Gingras, S., Carrière, M.C., Blais, Y., Labrie, F., Simard, J. (1998) Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells. J. Steroid Biochem. Mol. Biol., 65: 151-162. Breast Cancer 1998
<< previous | 1 | 2 | 3 | 4
next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards